Search Results - "de Nijs, Koen"

Medical costs of lung cancer by stage, histology and first-line treatment modality in the Netherlands (2012–2021) by de Nijs, Koen, de Koning, Harry J., van der Aalst, Carlijn, ten Haaf, Kevin

“…Lung cancer is a leading cause of mortality worldwide, with lung cancer treatment presenting a significant financial burden. The treatment landscape has…”
Get full text

Cost‐effectiveness of risk‐based low‐dose computed tomography screening for lung cancer in Switzerland by Tomonaga, Yuki, Nijs, Koen, Bucher, Heiner C., Koning, Harry, Haaf, Kevin

“…Throughout Europe, computed tomography (CT) screening for lung cancer is in a phase of clinical implementation or reimbursement evaluation. To efficiently…”
Get full text

Assessing the impact of increasing lung screening eligibility by relaxing the maximum years‐since‐quit threshold: A simulation modeling study by Meza, Rafael, Cao, Pianpian, Nijs, Koen, Jeon, Jihyoun, Smith, Robert A., Haaf, Kevin, Koning, Harry

“…Background In 2021, the US Preventive Services Task Force expanded its lung screening recommendation to include persons aged 50–80 years who had ever smoked…”
Get full text

Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness Analysis by Toumazis, Iakovos, Cao, Pianpian, de Nijs, Koen, Bastani, Mehrad, Munshi, Vidit, Hemmati, Mehdi, Ten Haaf, Kevin, Jeon, Jihyoun, Tammemägi, Martin, Gazelle, G Scott, Feuer, Eric J, Kong, Chung Yin, Meza, Rafael, de Koning, Harry J, Plevritis, Sylvia K, Han, Summer S

“…In their 2021 lung cancer screening recommendation update, the U.S. Preventive Services Task Force (USPSTF) evaluated strategies that select people based on…”
Get full text

The Impact of Model Assumptions on Personalized Lung Cancer Screening Recommendations by ten Haaf, Kevin, de Nijs, Koen, Simoni, Giulia, Alban, Andres, Cao, Pianpian, Sun, Zhuolu, Yong, Jean, Jeon, Jihyoun, Toumazis, Iakovos, Han, Summer S., Gazelle, G. Scott, Kong, Chung Ying, Plevritis, Sylvia K., Meza, Rafael, de Koning, Harry J.

“…Background Recommendations regarding personalized lung cancer screening are being informed by natural-history modeling. Therefore, understanding how…”
Get full text

Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening by Toumazis, Iakovos, de Nijs, Koen, Cao, Pianpian, Bastani, Mehrad, Munshi, Vidit, Ten Haaf, Kevin, Jeon, Jihyoun, Gazelle, G Scott, Feuer, Eric J, de Koning, Harry J, Meza, Rafael, Kong, Chung Yin, Han, Summer S, Plevritis, Sylvia K

“…The US Preventive Services Task Force (USPSTF) issued its 2021 recommendation on lung cancer screening, which lowered the starting age for screening from 55 to…”
Get more information

Projected effectiveness of lung cancer screening and concurrent smoking cessation support in the Netherlands by de Nijs, Koen, ten Haaf, Kevin, van der Aalst, Carlijn, de Koning, Harry J.

“…The NELSON trial demonstrated a 24% intention-to-screen reduction in lung cancer mortality from regular screening with low-dose computed tomography…”
Get full text